Signal Explorer

Clinical Trial Result Secondary Endpoint Mentioned Combination Therapy Mentioned Lead Asset Progress Clinical Hold

Patient Retention High Interim Data Positive Fda Aligned Executive Educational Background Disclosure Enrollment Ahead Of Schedule

Reimbursement Improving

Financing Activities Cash Flow Disclosure Non Employee Director Compensation Disclosed Liquidity Position Snapshot Disclosed Depreciation Expense Composition Disclosure Net Loss Reported Market Volatility Risk Disclosure Cash Flow Statement Investing Activities Rsu Psu Vesting Schedule Disclosed Operating Lease Rent Expense Disclosed Credit Risk Management Disclosure Other Income Expense Disclosure Cybersecurity Breach Reputational Harm Disclosure Reimbursement Price Pressure Risk Material Weakness In Internal Controls Disclosed Competition Disclosure

Sga Expense Comparison Disclosed Net Loss Reported Revenue Increase Attribution Disclosure Enrollment Ahead Of Schedule Patient Retention High Interim Data Positive Expanded Access Program Active Protocol Amended

Clinical Trial Result Indication Expansion Lead Asset Progress Secondary Endpoint Mentioned Patient Enrollment Velocity Clinical Hold

Ind Submission Planned

Auditor Appointment Ratification Record Date Disclosure Classified Board Director Election

Rsu Psu Vesting Schedule Disclosed Liquidity Position Snapshot Disclosed Financing Activities Cash Flow Disclosure Net Loss Reported Depreciation Expense Composition Disclosure Market Volatility Risk Disclosure Capital Raising Uncertainty Disclosed Cash Flow Statement Investing Activities Form S3 Shelf Registration Disclosure Codm Segment Reporting Disclosure Operating Lease Rent Expense Disclosed Sanctions Compliance Representation Other Income Expense Disclosure

Clinical Hold Clinical Trial Result

Net Loss Reported Revenue Increase Attribution Disclosure Enrollment Ahead Of Schedule Patient Retention High Interim Data Positive Protocol Amended Expanded Access Program Active Publication Positive

Clinical Trial Result Lead Asset Progress Clinical Hold Secondary Endpoint Mentioned Indication Expansion

Ind Submission Planned

Clinical Hold Active